Anita Assmann

Publications

Heinemann Klaas, Assmann Anita, Long term active surveillance study for oral contraceptives (LASS): final results on cardiovascular safety. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 360. DOI 10.1002.

Heinemann Klaas, Assmann Anita, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 365. DOI 10.1002.

Dinger Jürgen, Assmann Anita, Oral contraceptives and the risk of VTE: reanalysis of the EURAS/LASS study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 74.

Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 181.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in obese women. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 15.

Dinger Jürgen, Assmann Anita, Long-term active surveillance study for oral contraceptives (LASS): Impact of oral contraceptive use on the start of antihypertensive treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S232.

Dinger Jürgen, Assmann Anita, Moehner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.

Dinger Jürgen, Assmann Anita, Bardenheuer Kristina, Safety long-term active surveillance study for oral contraceptives (LASS): Results on venous and arterial thromboembolism. Eur J Conctracept Reprod Health Care. 2010; S1:128.

Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: Interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2010; 19:S31-32.

Dinger Jürgen, Barnett Clare, Moehner Sabine, Assmann Anita, Unintended pregnancies in women using intrauterine devices: Results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2010; 19:S242.

Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Heinemann Klaas, Leddin Janko, Drug utilization study on the prescribing indications of oral contraceptives in croatia. Pharmacoepidemiology and Drug Safety. 2010; 19:S55.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in adolescents. Eur J Contracept Reprod Health Care. 2010; 15;S1:81.

Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Leddin Janko, Unterschiede in der europäischen und US-amerikanischen Studienpopulation am Beispiel INAS-OC. Gesundheitswesen. 2010; 72:624.

Heinemann Lothar A , Dinger Jürgen, Assmann Anita, Do Minh Thai, Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare" Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014.

Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, International active surveillance study of women taking oral contraceptives (INAS-OC Study) BMC Medical Research Methodology. 2009; 9: 77.. 10.1186/1471-2288-9-77.

Dinger Jürgen, Assmann Anita, Altmann Matthias, Contraceptive efficacy of oral contraceptives under real life conditions; the impact of a 24-day regimen on contraceptive effectiveness. Pharmacoepidemiol Drug Saf. 2008; 17: S104.

Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.

Dinger Jürgen, Assmann Anita, Kuehl-Habich D, Oral contraceptives and the risk of arrhythmia: final results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2008; 17: S260.

Dinger Jürgen, Assmann Anita, Kolbeck A, Cardiovascular safety of oral hormone replacement: interim results from the EURAS-HRT study. Pharmacoepidemiol Drug Saf. 2008; 17: S270.

Dinger Jürgen, Assmann Anita, The safety of HRT under real life conditions: interim results from the EURAS HRT study. Gynecol Endocrinol. 2008; 24: S51.

van der Woude Fokke J , Heinemann Lothar A , Graf H, Lewis Michael, Moehner Sabine, Assmann Anita, Kuehl-Habich D, Analgesics use and ESRD in younger age: a case-control study BMC Nephrology. 2007; 8:15.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The safety and efficacy of oral contraceptives in teenagers: results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2007; 16: S13.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Interim results from the international active surveillance study of women taking oral contraceptives (INAS OC). Pharmacoepidemiology and Drug Safety. 2007; 16: S211.

Dinger Jürgen, Assmann Anita, Kuehl-Habich D, The safety of oral hormone replacement therapy under real life conditions: interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2007; 16: S213.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Design issues in active surveillance studies: experience from the EURAS studies.. Pharmacoepidemiology and Drug Safety. 2007; 16: S253.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.

Heinemann Lothar A , Assmann Anita, Dinger Jürgen, The risk of venous thromboembolism (VTE) in oral contraceptives: a new lesson. Pharmacoepidemiology and Drug Safety. 2006; 15: S24.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The European active surveillance study on oral contraceptives (EURAS-OC): final results after more than 130,000 WY of observatio. Pharmacoepidemiology and Drug Safety. 2006; 15: S26.

Assmann Anita, Dinger Jürgen, Heinemann Lothar A , European active surveillance of women taking HRT (EURAS-HRT). Pharmacoepidemiology and Drug Safety. 2006; 15: S73.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , International active surveillance study of women taking oral contraceptives (INAS-OC). Pharmacoepidemiology and Drug Safety. 2006; 15: S132.

Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The impact of obesity on the contraceptive reliability of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S140.

Spannagl M, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8.

Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Hilpert J, Spannagl M, VTE risk assessment – a prognostic model: BATER cohort study of young women Thrombosis Journal. 2005; 2005;3:5 (18 April 2005). DOI: 10.1186/1477-9560-3-5.

Heinemann Klaas, Assmann Anita, Lewis Michael, Garbe E, Heinemann Lothar A , Teichmann A T, Trend der HRT Nutzung in Deutschland 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. 2002; 43:508-511.

Heinemann Klaas, Lewis Michael, Assmann Anita, Garbe E, Heinemann Lothar A , Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 Zentralbl Gynakol. 2002; 124(2): 128-131. DOI: 10.1055/s-2002-24241.

Heinemann Klaas, Heinemann Lothar A , Assmann Anita, Schneider HPG, Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für die Deutsche Bevölkerung Zentralbl Gynakol. 2002; 124(3): 161-163. DOI: 10.1055/s-2002-32268.

Heinemann Lothar A , Assmann Anita, European Active Surveillance Study on Hormone Replacement Therapy. EURAS-HRT study protocol. Life and Medical Science Online. 2002; 3.

Heinemann Lothar A , Lewis Michael, Assmann Anita, Thiel C, Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use Contraception. 2002; Mar;65(3):207-14.

Thiel C, Heinemann Lothar A , Assmann Anita, Gründe für eine Veränderung der HRT-Therapie aus Sicht der Frauen. Zentralblatt für Gynäkologie . 2001; 123(7):390-398. DOI: 10.1055/s-2001-17036.

Heinemann Lothar A , Thiel C, Assmann Anita, Gründe und Häufigkeit von Wechsel/Stopp der Einnahme oraler Kontrazeptiva. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. Zentralbl Gynakol. 2001; 123(10): 568-577. DOI: 10.1055/s-2001-19090.

Heinemann Lothar A , Assmann Anita, Lewis Michael, How representative can be a cohort of volunteers for the general population? The German Cohort Study on Women' Health. Life and Medical Science Online. 2001; 2.

Heinemann Lothar A , Assmann Anita, Heinemann Klaas, Use of oral contraceptives containing dienogest and risk of venous thromboembolism; an extended summary report. Life and Medical Science Online. 2001; 2.

Heinemann Lothar A , Thiel C, Assmann Anita, Zimmermann T, Hummel W, Vermeulen A, Sex differences of „climacteric symptoms“ with increasing age? A pooled analysis of cross-sectional population-based surveys Aging Male. 2001; Sep;3(3):124-31.

Schramm W, Heinemann Lothar A , Spannagl M, Dick A, Assmann Anita, Die BAyerischen Thrombo-Embolie-Risiko Kohortenstudie (BATER). Studienprotokoll, Stand der Untersuchung und erste Ergebnisse.. Dtsch Med Wschr. 2000; 125:2-6.

Heinemann Lothar A , Thorogood M, Kerle K M, Assmann Anita, Do Minh Thai, Use of psychotropic drugs and risk of cardiovascular events. Life and Medical Science Online. 2000; 1.